Cleared Traditional

K183167 - Boston ES (enflufocon A) Rigid Gas Permeable Contact Lens (FDA 510(k) Clearance)

Also includes:
Boston EO (enflufocon B) Rigid Gas Permeable Contact Lens Boston XO (hexafocon A) Rigid Gas Permeable Contact Lens Boston XO2 (hexafocon B) Rigid Gas Permeable Contact Lens
Feb 2019
Decision
89d
Days
Class 2
Risk

K183167 is an FDA 510(k) clearance for the Boston ES (enflufocon A) Rigid Gas Permeable Contact Lens. This device is classified as a Lens, Contact (other Material) - Daily (Class II - Special Controls, product code HQD).

Submitted by Bausch & Lomb, Incorporated (Rochester, US). The FDA issued a Cleared decision on February 12, 2019, 89 days after receiving the submission on November 15, 2018.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5916.

Submission Details

510(k) Number K183167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 2018
Decision Date February 12, 2019
Days to Decision 89 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code HQD — Lens, Contact (other Material) - Daily
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.5916